A Study to Evaluate the Performance and Safety of GP0045 for Correction of Moderate to Severe Nasolabial Folds

Inclusion Criteria: * Ability to adequately understand the verbal explanations and the written subject information provided in local language and ability to give consent to participate in the study * Signed and dated informed consent to participate in the study, including photo consent * Subjects with intent to undergo correction of both nasolabial folds Exclusion Criteria: * Known/previous allergy or hypersensitivity to any injectable hyaluronic acid (HA) gel * Known/previous allergy or hypersensitivity to local anesthetics, e.g. lidocaine or other amide-type anesthetics * Any condition (medical or other) that, in the opinion of the Investigator, would make the subject unsuitable for inclusion (e.g. a chronic, relapsing or hereditary disease that may interfere with the outcome of the study) * Participation in any other clinical study with an investigational product within 30 days before treatment